Paul Byrne

Paul Byrne is the Global Head of MS, Neuroimmunology, and Neuromuscular Disease at Roche, a position they have held since 2025. Previously, they served as an International Product Manager at Wellcome PLC and held various leadership roles at Roche, including Global Franchise Head and Integrated Strategy Leader for OCREVUS. Paul has also worked as the Neuroscience Business Unit Head at Serono Pharma and as an International Marketing Director at Elan Pharmaceuticals. Their extensive experience in global pharmaceutical strategy and neuroscience has significantly contributed to advancement in these fields.